• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-PD-1 Antibody Therapy Induces Hashimoto's Disease with an Increase in Peripheral Blood Follicular Helper T Cells.

作者信息

Torimoto Keiichi, Okada Yosuke, Nakayamada Shingo, Kubo Satoshi, Tanaka Yoshiya

机构信息

First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health , Kitakyushyu, Japan .

出版信息

Thyroid. 2017 Oct;27(10):1335-1336. doi: 10.1089/thy.2017.0062. Epub 2017 Aug 3.

DOI:10.1089/thy.2017.0062
PMID:28699391
Abstract
摘要

相似文献

1
Anti-PD-1 Antibody Therapy Induces Hashimoto's Disease with an Increase in Peripheral Blood Follicular Helper T Cells.抗程序性死亡蛋白1（PD-1）抗体疗法可诱发桥本氏病，并伴有外周血滤泡辅助性T细胞增多。
Thyroid. 2017 Oct;27(10):1335-1336. doi: 10.1089/thy.2017.0062. Epub 2017 Aug 3.
2
Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine.用左甲状腺素替代治疗后，甲状腺功能减退性桥本甲状腺炎患者自身免疫过程受到下调。
Eur Cytokine Netw. 2009 Mar;20(1):27-32. doi: 10.1684/ecn.2009.0147.
3
A case of de novo palmoplantar psoriasis with psoriatic arthritis and autoimmune hypothyroidism after receiving nivolumab therapy.一例接受纳武单抗治疗后新发掌跖银屑病伴银屑病关节炎和自身免疫性甲状腺功能减退症的病例。
Dermatol Online J. 2017 Aug 15;23(8):13030/qt12n4m6pm.
4
Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.重度桥本氏病中Th1/Th2细胞比例升高以及难治性格雷夫斯病中Th17细胞比例升高。
Thyroid. 2009 May;19(5):495-501. doi: 10.1089/thy.2008.0423.
5
Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?纳武单抗治疗后免疫检查点抑制剂相关的中枢神经系统自身免疫性疾病（ICICAD）：药物性自身免疫性脑炎的一种新实体？
Eur J Cancer. 2017 Dec;87:205-208. doi: 10.1016/j.ejca.2017.09.026. Epub 2017 Oct 16.
6
Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.左甲状腺素治疗慢性自身免疫性甲状腺炎（桥本甲状腺炎）患者抗甲状腺过氧化物酶抗体的长期随访
Thyroid. 2008 Jul;18(7):755-60. doi: 10.1089/thy.2008.0008.
7
Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis.外周血单个核细胞中 Th1/Th17 的分化失衡可能导致桥本甲状腺炎的发病机制。
Scand J Immunol. 2010 Sep;72(3):250-5. doi: 10.1111/j.1365-3083.2010.02425.x.
8
Hashimoto's thyroiditis following Graves' disease.格雷夫斯病后发生的桥本甲状腺炎。
Acta Med Indones. 2010 Jan;42(1):31-5.
9
The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis.左甲状腺素和硒代蛋氨酸对桥本甲状腺炎妇女淋巴细胞和单核细胞细胞因子释放的影响。
J Clin Endocrinol Metab. 2011 Jul;96(7):2206-15. doi: 10.1210/jc.2010-2986. Epub 2011 Apr 20.
10
Memory and Hashimoto's thyroiditis under levothyroxine treatment: is there a placebo or nocebo effect?左甲状腺素治疗下的记忆与桥本甲状腺炎：是否存在安慰剂或反安慰剂效应？
Endocrine. 2017 Jul;57(1):183-186. doi: 10.1007/s12020-017-1262-0. Epub 2017 Feb 16.

引用本文的文献

1
Correlation between different levels of thyroid autoantibodies and immune checkpoint inhibitor-associated thyroid dysfunction.不同水平甲状腺自身抗体与免疫检查点抑制剂相关甲状腺功能障碍之间的相关性
Front Endocrinol (Lausanne). 2025 Aug 13;16:1620718. doi: 10.3389/fendo.2025.1620718. eCollection 2025.
2
Risk factors and outcomes of thyroid immune-related adverse events following PD-1/PD-L1 inhibitors treatment in a large tertiary Chinese center.中国一家大型三级中心中，PD-1/PD-L1抑制剂治疗后甲状腺免疫相关不良事件的危险因素及结局
BMC Endocr Disord. 2025 Jul 14;25(1):171. doi: 10.1186/s12902-025-01986-1.
3
Risk factors of immune-related endocrine toxicities in non-small cell lung cancer patients treated with pembrolizumab and its impact on patient outcomes: a multicenter retrospective study.
帕博利珠单抗治疗的非小细胞肺癌患者免疫相关内分泌毒性的危险因素及其对患者预后的影响：一项多中心回顾性研究
BMC Pulm Med. 2025 Mar 13;25(1):111. doi: 10.1186/s12890-025-03570-8.
4
Common endocrine system adverse events associated with immune checkpoint inhibitors.与免疫检查点抑制剂相关的常见内分泌系统不良事件。
Cancer Pathog Ther. 2023 Dec 1;2(3):164-172. doi: 10.1016/j.cpt.2023.11.005. eCollection 2024 Jul.
5
Thyroid disorders induced by immune checkpoint inhibitors.免疫检查点抑制剂引起的甲状腺疾病。
Endocrine. 2024 Jul;85(1):67-79. doi: 10.1007/s12020-024-03718-2. Epub 2024 Feb 12.
6
Dynamic follow-up of the effects of programmed death 1 inhibitor treatment on thyroid function and sonographic features in patients with hepatocellular carcinoma.肝细胞癌患者程序性死亡1抑制剂治疗对甲状腺功能及超声特征影响的动态随访
Endocr Connect. 2022 May 23;11(5):e220065. doi: 10.1530/EC-22-0065.
7
The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries.与免疫检查点抑制剂相关的甲状腺疾病连续谱：仍有许多待解疑问。
Cancers (Basel). 2021 Oct 21;13(21):5277. doi: 10.3390/cancers13215277.
8
PD-1-induced proliferating T cells exhibit a distinct transcriptional signature.PD-1 诱导的增殖 T 细胞表现出独特的转录特征。
Immunology. 2021 Nov;164(3):555-568. doi: 10.1111/imm.13388. Epub 2021 Jul 12.
9
Graves' Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review).免疫检查点抑制剂治疗期间的格雷夫斯病（病例系列及文献综述）
Cancers (Basel). 2021 Apr 17;13(8):1944. doi: 10.3390/cancers13081944.
10
Expression of miRNA-146b-5p in patients with thyroid cancer in combination with Hashimoto's disease and its clinical significance.miRNA-146b-5p在甲状腺癌合并桥本氏病患者中的表达及其临床意义。
Oncol Lett. 2019 Jun;17(6):4871-4876. doi: 10.3892/ol.2019.10173. Epub 2019 Mar 20.